title: PHARMAC seeks clinical feedback on its cost-utility analysis methodology.
authors.forename: Rachel
authors.initials: R
authors.lastname: Grocott
authors.forename: Peter
authors.initials: P
authors.lastname: Moodie
mesh_terms: D003362:Cost-Benefit Analysis / Q000379:methods; D004335:Drug and Narcotic Control; D017850:Economics, Pharmaceutical; D006801:Humans; D009520:New Zealand